An isogenic cell line panel for sequence-based screening of targeted anticancer drugs-Reference-Cited by-同舟云学术

An isogenic cell line panel for sequence-based screening of targeted anticancer drugs

Published:2022-06 Issue:6 Volume:25 Page:104437
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Cook Ashley L.^ORCID,Wyhs Nicolas,Sur Surojit,Ptak Blair,Popoli Maria,Dobbyn Laura,Papadopoulos Tasos,Bettegowda Chetan,Papadopoulos Nickolas,Vogelstein Bert,Zhou Shibin,Kinzler Kenneth W.

Funder

Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University

American Indian Graduate Center

Mark Foundation For Cancer Research

Lustgarten Foundation

National Institutes of Health

Virginia and D K Ludwig Fund for Cancer Research

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference39 articles.

1. Phase II, Single-Arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients with MYC Family Amplification or CDKN2A Mutation Combined with TP53 Mutation;Center,2016

2. Design, synthesis and selection of DNA-encoded small-molecule libraries;Clark;Nat. Chem. Biol.,2009

3. Detection and localization of surgically resectable cancers with a multi-analyte blood test;Cohen;Science,2018

4. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers;Diaz Jr;Nature,2012

5. CRAVAT: cancer-related analysis of variants toolkit;Douville;Bioinformatics,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape;2024-07-29

2. Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape;2024-07-29

3. Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape;2024-05-07

4. Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape;2023-12-29

5. CRISPR single base-editing: in silico predictions to variant clonal cell lines;Human Molecular Genetics;2023-06-27